Creo Medical Group PLC (LON:CREO – Get Free Report)’s share price shot up 3.9% during mid-day trading on Monday . The stock traded as high as GBX 33.98 ($0.43) and last traded at GBX 33.50 ($0.42). 383,502 shares traded hands during mid-day trading, a decline of 44% from the average session volume of 687,521 shares. The stock had previously closed at GBX 32.25 ($0.41).
Creo Medical Group Stock Up 3.9 %
The firm has a fifty day simple moving average of GBX 34.95 and a 200-day simple moving average of GBX 36.70. The company has a market capitalization of £121.10 million, a P/E ratio of -478.57 and a beta of 0.86. The company has a quick ratio of 2.19, a current ratio of 3.83 and a debt-to-equity ratio of 13.88.
Creo Medical Group Company Profile
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
Featured Articles
- Five stocks we like better than Creo Medical Group
- Low PE Growth Stocks: Unlocking Investment Opportunities
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- What is a SEC Filing?
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Dividend Payout Ratio Calculator
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.